Top

World Journal of Surgical Oncology

Published in:

Open Access 01-12-2024 | Radiotherapy | Research

Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery

Authors: Hao Cheng, Jin-Hong Xu, Jia-Qi He, Xi-Yang Yang, Xu-Ning Shen, Xue-Lian Xu

Published in: World Journal of Surgical Oncology | Issue 1/2024

Abstract

Background

Lip squamous cell carcinoma (LSCC) was one of the most common cancer types of head and neck tumors. This study aimed to find more predictors of the prognosis in postoperative LSCC patients.

Methods

A total of 147 LSCC patients between June 2012 and June 2018 were collected from two tertiary care institutions. There were 21 clinicopathological factors included and analyzed in our study. The univariate and multivariate Cox regression analyses were performed to find the independent prognostic factors for predicting progression-free survival (PFS) and overall survival (OS) in postoperative LSCC patients. The role of adjuvant radiotherapy in various subgroups was displayed by Kaplan–Meier plots.

Results

The 1-, 3-, and 5-year PFS of postoperative LSCC patients were 88.4%, 70.1%, and 57.8%, respectively. Similarly, the 1-, 3-, and 5-year OS of postoperative LSCC patients were 94.6%, 76.9%, and 69.4%, respectively. The results suggested that postoperative LSCC patients with age at diagnosis ≥ 70 years, grade with moderate or poor differentiate, the American Joint Committee on Cancer (AJCC) stage IV, higher systemic immune-inflammation index (SII), surgical margin < 5, and age-adjusted Charlson Comorbidity Index (ACCI) ≥ 5 tend to have a poorer PFS (all P < 0.05). Besides, postoperative LSCC patients with age at diagnosis ≥ 70 years, AJCC stage IV, higher GPS, higher SII, and ACCI ≥ 5 tend to have a worse OS (all P < 0.05). Additionally, postoperative patients with LSCC in the subgroup of ACCI < 5 and AJCC III–IV stage was more likely to benefit from adjuvant radiotherapy, but not for the other subgroups.

Conclusion

We identified a series of significant immune-inflammation-related and comorbidity-related clinicopathological factors associated with the prognosis of postoperative LSCC patients by local data from two tertiary care institutions in China, which can be helpful for patients and surgeons to pay more attention to nutrition, inflammation, and complications and finally obtained a better prognosis.

Available only for authorised users

Han AY, Kuan EC, Mallen-St Clair J, Alonso JE, Arshi A, St John MA. Epidemiology of squamous cell carcinoma of the lip in the United States: a population-based cohort analysis. JAMA Otolaryngol Head Neck Surg. 2016;142(12):1216–23.PubMedCrossRef

Farhadi K, Rojanaworarit C, Bhurosy T, Olokunlade T, Karaye IM. Trends in lip, oral cavity, and pharyngeal cancer mortality in the United States, 1999–2019. J Oral Pathol Med. 2022;51(9):763–70.PubMedCrossRef

Ellington TD, Henley SJ, Senkomago V, O’Neil ME, Wilson RJ, Singh S, Thomas CC, Wu M, Richardson LC. Trends in incidence of cancers of the oral cavity and pharynx - United States 2007–2016. MMWR Morb Mortal Wkly Rep. 2020;69(15):433–8.PubMedPubMedCentralCrossRef

Miranda-Filho A, Bray F. Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncol. 2020;102:104551.PubMedCrossRef

Bota JP, Lyons AB, Carroll BT. Squamous cell carcinoma of the lip-a review of squamous cell carcinogenesis of the mucosal and cutaneous junction. Dermatol Surg. 2017;43(4):494–506.PubMedCrossRef

Hashim D, Genden E, Posner M, Hashibe M, Boffetta P. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol. 2019;30(5):744–56.PubMedPubMedCentralCrossRef

Shrestha AD, Vedsted P, Kallestrup P, Neupane D. Prevalence and incidence of oral cancer in low- and middle-income countries: a scoping review. Eur J Cancer Care (Engl). 2020;29(2):e13207.PubMedCrossRef

Unsal AA, Unsal AB, Henn TE, Baredes S, Eloy JA. Cutaneous squamous cell carcinoma of the lip: a population-based analysis. Laryngoscope. 2018;128(1):84–90.PubMedCrossRef

Kerawala C, Roques T, Jeannon JP, Bisase B. Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S83–9.PubMedPubMedCentralCrossRef

10.

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version). Chin J Cancer Res. 2019;31(1):84–98. https://doi.org/10.21147/j.issn.1000-9604.2019.01.05. PMID: 30996568.

11.

Schilling C, Stoeckli SJ, Vigili MG, de Bree R, Lai SY, Alvarez J, Christensen A, Cognetti DM, D’Cruz AK, Frerich B, et al. Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer. Head Neck. 2019;41(8):2655–64.PubMedCrossRef

12.

Giammarile F, Schilling C, Gnanasegaran G, Bal C, Oyen WJG, Rubello D, Schwarz T, Tartaglione G, Miller RN, Paez D, et al. The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2019;46(3):623–37.PubMedCrossRef

13.

Cervenka B, Pipkorn P, Fagan J, Zafereo M, Aswani J, Macharia C, Kundiona I, Mashamba V, Zender C, Moore M. Oral cavity cancer management guidelines for low-resource regions. Head Neck. 2019;41(3):799–812.PubMedCrossRef

14.

Lin YW, Kang WP, Hong CQ, Huang BL, Qiu ZH, Liu CT, Chu LY, Xu YW, Guo HP, Wu FC. Nutritional and immune-related indicators-based nomogram for predicting overall survival of surgical oral tongue squamous cell carcinoma. Sci Rep. 2023;13(1):8525.PubMedPubMedCentralCrossRef

15.

Liu TPJ, David M, Clark JR, Low TH, Batstone MD. Prediction nomogram development and validation for postoperative radiotherapy in the management of oral squamous cell carcinoma. Head Neck. 2023;45(6):1503–10.PubMedCrossRef

16.

Jiang S, Dong Y. Human papillomavirus and oral squamous cell carcinoma: a review of HPV-positive oral squamous cell carcinoma and possible strategies for future. Curr Probl Cancer. 2017;41(5):323–7.PubMedCrossRef

17.

Sumer BD. Editorial: cancer staging in squamous cell carcinoma of the vermilion lip. Ann Surg Oncol. 2021;28(6):2944–5.PubMedCrossRef

18.

Zanoni DK, Montero PH, Migliacci JC, Shah JP, Wong RJ, Ganly I, Patel SG. Survival outcomes after treatment of cancer of the oral cavity (1985–2015). Oral Oncol. 2019;90:115–21.PubMedPubMedCentralCrossRef

19.

Du E, Mazul AL, Farquhar D, Brennan P, Anantharaman D, Abedi-Ardekani B, Weissler MC, Hayes DN, Olshan AF, Zevallos JP. Long-term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status. Laryngoscope. 2019;129(11):2506–13.PubMedPubMedCentralCrossRef

20.

Wolfer S, Kunzler A, Foos T, Ernst C, Leha A, Schultze-Mosgau S. Gender and risk-taking behaviors influence the clinical presentation of oral squamous cell carcinoma. Clin Exp Dent Res. 2022;8(1):141–51.PubMedPubMedCentralCrossRef

21.

Fan Y, Zheng L, Mao MH, Huang MW, Liu SM, Zhang J, Li SL, Zheng L, Zhang JG. Survival analysis of oral squamous cell carcinoma in a subgroup of young patients. Asian Pac J Cancer Prev. 2014;15(20):8887–91.PubMedCrossRef

22.

Sun Q, Fang Q, Guo S. A comparison of oral squamous cell carcinoma between young and old patients in a single medical center in China. Int J Clin Exp Med. 2015;8(8):12418–23.PubMedPubMedCentral

23.

Borsetto D, Higginson JA, Aslam A, Al-Qamachi L, Dhanda J, Marioni G, Franchella S, Frigo A, Praveen P, Martin T, et al. Factors affecting prognosis in locoregional recurrence of oral squamous cell carcinoma. J Oral Pathol Med. 2019;48(3):206–13.PubMedCrossRef

24.

Kakasheva-Mazhenkovska L, Kostovski M, Gjokik G, Janevska V. Assessment of density of neovascularization in lower lip squamous cell carcinoma in relation to neoplasm differentiation grade in patients with and without neck lymph nodes metastasis. Open Access Maced J Med Sci. 2019;7(1):19–23.PubMedPubMedCentralCrossRef

25.

Bulbul MG, Zenga J, Tarabichi O, Parikh AS, Sethi RK, Robbins KT, Puram SV, Varvares MA. Margin practices in oral cavity cancer resections: survey of American Head and Neck Society members. Laryngoscope. 2021;131(4):782–7.PubMedCrossRef

26.

Tasche KK, Buchakjian MR, Pagedar NA, Sperry SM. Definition of “close margin” in oral cancer surgery and association of margin distance with local recurrence rate. JAMA Otolaryngol Head Neck Surg. 2017;143(12):1166–72.PubMedPubMedCentralCrossRef

27.

Lin MC, Leu YS, Chiang CJ, Ko JY, Wang CP, Yang TL, Chen TC, Chen CN, Chen HL, Liao CT, et al. Adequate surgical margins for oral cancer: a Taiwan Cancer Registry national database analysis. Oral Oncol. 2021;119:105358.PubMedCrossRef

28.

Kanatas A, Walshaw EG, Wu J, Fabbroni G, Chengot P. Prognostic factors in oral cancer surgery - results from a UK tertiary centre. Eur J Surg Oncol. 2023;49(4):755–9.PubMedCrossRef

29.

Bugada D, Allegri M, Lavand’homme P, De Kock M, Fanelli G. Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients. Biomed Res Int. 2014;2014:142425.PubMedPubMedCentralCrossRef

30.

Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41.PubMedPubMedCentralCrossRef

31.

Sautes-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19(6):307–25.PubMedCrossRef

32.

Nost TH, Alcala K, Urbarova I, Byrne KS, Guida F, Sandanger TM, Johansson M. Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 2021;36(8):841–8.PubMedPubMedCentralCrossRef

33.

Gallego A, Mendiola M, Hernando B, Berjon A, Cadiz A, Chaves-Urbano B, Heredia-Soto V, Spagnolo E, Hernandez Gutierrez A, Hardisson D, et al. Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer. Int J Gynecol Cancer. 2022;32(8):1009–16.PubMedCrossRef

34.

Marques P, de Vries F, Dekkers OM, van Furth WR, Korbonits M, Biermasz NR, Pereira AM. Pre-operative serum inflammation-based scores in patients with pituitary adenomas. Pituitary. 2021;24(3):334–50.PubMedCrossRef

35.

Yang T, Mao P, Chen X, Niu X, Xu G, Bai X, Xie W. Inflammatory biomarkers in prognostic analysis for patients with glioma and the establishment of a nomogram. Oncol Lett. 2019;17(2):2516–22.PubMed

36.

Ahmad J, Grimes N, Farid S, Morris-Stiff G. Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review. Hepatobiliary Pancreat Dis Int. 2014;13(5):474–81.PubMedCrossRef

37.

Quail DF, Amulic B, Aziz M, Barnes BJ, Eruslanov E, Fridlender ZG, Goodridge HS, Granot Z, Hidalgo A, Huttenlocher A, et al. Neutrophil phenotypes and functions in cancer: a consensus statement. J Exp Med. 2022;219(6):e20220011.PubMedPubMedCentralCrossRef

38.

Li J, Cao D, Huang Y, Xiong Q, Tan D, Liu L, Lin T, Wei Q. The prognostic and clinicopathological significance of systemic immune-inflammation index in bladder cancer. Front Immunol. 2022;13:865643.PubMedPubMedCentralCrossRef

39.

Huang H, Liu Q, Zhu L, Zhang Y, Lu X, Wu Y, Liu L. Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer. Sci Rep. 2019;9(1):3284.PubMedPubMedCentralCrossRef

40.

Wang D, Hu X, Xiao L, Long G, Yao L, Wang Z, Zhou L. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg. 2021;25(2):421–7.PubMedCrossRef

41.

Ji Y, Wang H. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis. World J Surg Oncol. 2020;18(1):197.PubMedPubMedCentralCrossRef

42.

Meng L, Yang Y, Hu X, Zhang R, Li X. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis. J Transl Med. 2023;21(1):79.PubMedPubMedCentralCrossRef

43.

Yamamoto T, Kawada K, Obama K. Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients. Int J Mol Sci. 2021;22(15):8002.PubMedPubMedCentralCrossRef

44.

Toyokawa T, Muguruma K, Yoshii M, Tamura T, Sakurai K, Kubo N, Tanaka H, Lee S, Yashiro M, Ohira M. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer. BMC Cancer. 2020;20(1):517.PubMedPubMedCentralCrossRef

45.

Kudou K, Nakashima Y, Haruta Y, Nambara S, Tsuda Y, Kusumoto E, Ando K, Kimura Y, Hashimoto K, Yoshinaga K, et al. Comparison of inflammation-based prognostic scores associated with the prognostic impact of adenocarcinoma of esophagogastric junction and upper gastric cancer. Ann Surg Oncol. 2021;28(4):2059–67.PubMedCrossRef

46.

Wang C, He W, Yuan Y, Zhang Y, Li K, Zou R, Liao Y, Liu W, Yang Z, Zuo D, et al. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy. Liver Int. 2020;40(1):229–39.PubMedCrossRef

47.

Iwai N, Okuda T, Sakagami J, Harada T, Ohara T, Taniguchi M, Sakai H, Oka K, Hara T, Tsuji T, et al. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Sci Rep. 2020;10(1):18758.PubMedPubMedCentralCrossRef

48.

Zhou S, Zhang XH, Zhang Y, Gong G, Yang X, Wan WH. The age-adjusted Charlson Comorbidity Index predicts prognosis in elderly cancer patients. Cancer Manag Res. 2022;14:1683–91.PubMedPubMedCentralCrossRef

49.

Takahara N, Nakai Y, Saito K, Sasaki T, Suzuki Y, Inokuma A, Oyama H, Kanai S, Suzuki T, Sato T, et al. The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy. J Gastroenterol Hepatol. 2020;35(10):1828–35.PubMedCrossRef

50.

Qu WF, Zhou PY, Liu WR, Tian MX, Jin L, Jiang XF, Wang H, Tao CY, Fang Y, Zhou YF, et al. Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection. Ann Transl Med. 2020;8(7):487.PubMedPubMedCentralCrossRef

Title: Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery
Authors: Hao Cheng
Jin-Hong Xu
Jia-Qi He
Xi-Yang Yang
Xu-Ning Shen
Xue-Lian Xu
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: Radiotherapy
Published in: World Journal of Surgical Oncology / Issue 1/2024
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/s12957-024-03313-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2024

Patients with high nuclear grade pT1-ccRCC are more suitable for radical nephrectomy than partial nephrectomy: a multicenter retrospective study using propensity score

Anatomical variants of the intercostobrachial nerve and its preservation during surgery, a systematic review and meta-analysis

Malignant myoepithelioma of the external auditory canal — a rare case report with literature review and clinical importance of foramen of Huschke

Involvement of CX3CR1+ cells appearing in the abdominal cavity in the immunosuppressive environment immediately after gastric cancer surgery

Clinical efficiency of three-port inflatable robot-assisted thoracoscopic surgery in mediastinal tumor resection

Association between pathologic complete response and biochemical indicators after neoadjuvant therapy for HER2-positive breast cancer